Aytu Biopharma (AYTU) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to $30.0 million.
- Aytu Biopharma's Cash & Current Investments rose 4719.58% to $30.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $30.0 million, marking a year-over-year increase of 4719.58%. This contributed to the annual value of $31.0 million for FY2025, which is 5471.36% up from last year.
- Per Aytu Biopharma's latest filing, its Cash & Current Investments stood at $30.0 million for Q4 2025, which was up 4719.58% from $32.6 million recorded in Q3 2025.
- Aytu Biopharma's Cash & Current Investments' 5-year high stood at $50.2 million during Q2 2021, with a 5-year trough of $18.2 million in Q1 2025.
- Moreover, its 5-year median value for Cash & Current Investments was $21.7 million (2023), whereas its average is $26.8 million.
- In the last 5 years, Aytu Biopharma's Cash & Current Investments crashed by 6139.81% in 2022 and then soared by 6227.37% in 2025.
- Aytu Biopharma's Cash & Current Investments (Quarter) stood at $35.3 million in 2021, then tumbled by 44.72% to $19.5 million in 2022, then rose by 0.14% to $19.5 million in 2023, then rose by 4.45% to $20.4 million in 2024, then soared by 47.2% to $30.0 million in 2025.
- Its Cash & Current Investments stands at $30.0 million for Q4 2025, versus $32.6 million for Q3 2025 and $31.0 million for Q2 2025.